More specifically, we demonstrated that the depletion of H19 in glioblastoma cells is translated into a specific reduction of EZH2 binding and H3K27 trimethylation at the NKD1 promoter, with a consequent increase of Nkd1 levels. This evidence concerns the gene NKD1 and glioblastoma.